Breakthrough Immunotherapy Helps Patients With Locally Advanced Head and Neck Cancer A pivotal advance in the treatment of locally advanced head and neck cancer centers on pembrolizumab, an immunotherapy drug already used in several cancers. In a recent trial, this therapy was integrated into a comprehensive treatment plan that combines surgery, radiotherapy, and chemotherapy, and…